$243 Million is the total value of ADAMS STREET PARTNERS LLC's 9 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 75.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RMNI | Rimini Street, Inc. | $72,345,879 | -5.8% | 23,565,433 | 0.0% | 29.81% | -2.3% | |
PCTY | Paylocity Holding Corporation | $61,760,122 | -23.3% | 468,412 | 0.0% | 25.45% | -20.4% | |
PDD | New | PDD Holdings, Inc.ads | $41,279,380 | – | 310,488 | +100.0% | 17.01% | – |
QTWO | Sell | Q2 Holdings, Inc. | $35,004,009 | -14.3% | 580,209 | -25.4% | 14.42% | -11.2% |
Sell | Mineralys Therapeutics, Inc. | $19,757,930 | -18.4% | 1,688,712 | -10.0% | 8.14% | -15.4% | |
CRVS | Corvus Pharmaceuticals, Inc. | $5,961,621 | +2.2% | 3,275,616 | 0.0% | 2.46% | +6.0% | |
Vacasa, Inc. | $4,569,136 | -28.6% | 938,221 | 0.0% | 1.88% | -25.9% | ||
New | Maplebear, Inc. | $1,535,296 | – | 47,769 | +100.0% | 0.63% | – | |
VERA | New | Vera Therapeutics, Inc. | $474,465 | – | 13,114 | +100.0% | 0.20% | – |
Exit | Amplitude, Inc. | $0 | – | -23,271 | -100.0% | -0.10% | – | |
CRWD | Exit | CrowdStrike Holdings, Inc. | $0 | – | -1,125 | -100.0% | -0.14% | – |
Exit | Couchbase, Inc. | $0 | – | -21,163 | -100.0% | -0.22% | – | |
LZ | Exit | LegalZoom.com, Inc. | $0 | – | -45,234 | -100.0% | -0.24% | – |
CFLT | Exit | Confluent, Inc. | $0 | – | -108,538 | -100.0% | -1.32% | – |
COIN | Exit | Coinbase Global, Inc. | $0 | – | -45,133 | -100.0% | -4.75% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Paylocity Holding Corporation | 38 | Q2 2024 | 52.0% |
Q2 Holdings, Inc. (fka CBG Holdings, Inc.) | 38 | Q2 2024 | 36.6% |
Corvus Pharmaceuticals, Inc. | 34 | Q2 2024 | 13.7% |
Rimini Street, Inc. | 27 | Q2 2024 | 36.9% |
Aptinyx, Inc. | 20 | Q1 2023 | 17.5% |
magicJack VocalTec Ltd.(fka VocalTec Communications Ltd./Ymax Corporation) | 18 | Q4 2018 | 71.4% |
Fusion Pharmaceuticals, Inc. | 15 | Q4 2023 | 11.4% |
OncoMed Pharmaceuticals, Inc. | 12 | Q4 2017 | 7.5% |
Vacasa, Inc. | 11 | Q2 2024 | 24.0% |
Icosavax, Inc. | 9 | Q3 2023 | 11.6% |
View ADAMS STREET PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Mineralys Therapeutics, Inc. | February 14, 2024 | 2,302,329 | 5.6% |
Vacasa, Inc. | February 14, 2024 | 938,225 | 7.5% |
Icosavax, Inc. | November 24, 2023 | 2,095,087 | 4.2% |
Aptinyx Inc. | June 27, 2023 | 5,395,996 | 8.0% |
Fusion Pharmaceuticals Inc. | February 14, 2022 | 2,947,809 | 6.8% |
Rimini Street, Inc. | February 14, 2022 | 23,659,431 | 27.2% |
Paylocity Holding Corp | February 14, 2020 | 1,738,428 | 3.2% |
Aptinyx Inc. | February 13, 2019 | 4,030,628 | 12.0% |
Q2 Holdings, Inc. | February 13, 2019 | 1,643,275 | 3.8% |
Corvus Pharmaceuticals, Inc. | March 21, 2018 | 3,275,616 | 15.5% |
View ADAMS STREET PARTNERS LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
40-APP | 2024-09-23 |
APP WD | 2024-09-11 |
N-PX | 2024-08-30 |
13F-HR | 2024-08-14 |
4 | 2024-06-07 |
13F-HR | 2024-05-14 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13D/A | 2023-11-24 |
View ADAMS STREET PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.